grant
Comprehensive multimodal analysis of patients with neuroimmunological diseases
Organization NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESLocation UNITED STATES
NIHUS FederalResearch GrantFY2025APOEAcquired brain injuryAdhesionsAffectAgeAll of Us ProgramAll of Us Research ProgramAll of Us Research ProjectAmyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis Motor Neuron DiseaseAntigenic DeterminantsAoURPApo-EApoE proteinApolipoprotein EApolipoproteinsAssayAutoimmune DiseasesAutologousB blood cellsB cellB cell clonalityB cell receptor clonalityB cellsB-Cell ActivationB-CellsB-LymphocytesB-cellBBB disruptionBCR clonalityBindingBinding DeterminantsBioassayBiological AssayBiologyBlood PlasmaBody TissuesBrainBrain InjuriesBrain Nervous SystemBurkitt HerpesvirusBurkitt Lymphoma VirusCCR6CCR6 geneCD8CD8 CellCD8 T cellsCD8 lymphocyteCD8+ T cellCD8+ T-LymphocyteCD8-Positive LymphocytesCD8-Positive T-LymphocytesCD8BCD8B1CD8B1 geneCITE sequencingCITE-seqCITEseqCKRL3CMVCNS DiseasesCNS InjuryCNS Nervous SystemCNS disorderCOVID crisisCOVID epidemicCOVID pandemicCOVID-19 crisisCOVID-19 epidemicCOVID-19 eraCOVID-19 global health crisisCOVID-19 global pandemicCOVID-19 health crisisCOVID-19 pandemicCOVID-19 periodCOVID-19 public health crisisCOVID-19 yearsCaringCategoriesCell BodyCell DegranulationCell LineCell PhoneCellLineCellsCellular Indexing of Transcriptomes and Epitopes by SequencingCellular PhoneCellular TelephoneCentral Nervous SystemCentral Nervous System DiseasesCentral Nervous System DisordersChemokine Receptor GeneChemokine Receptor-Like 3Chemotactic CytokinesChoroid Plexus EpitheliumClinicalClonal ExpansionCo-cultureCocultivationCocultureCoculture TechniquesContrast-Enhancing LesionCytomegalovirusDangerousnessDataDetectionDevelopmentDiagnosisDiagnosticDigital biomarkerDiseaseDisease ProgressionDisorderDisseminated SclerosisDropsEB virusEBVEBV InfectionsEarly DiagnosisEarly treatmentEncephalonEndothelial CellsEndotheliumEnhancing LesionEpidemiologyEpitopesEpstein Barr VirusEpstein-Barr Virus InfectionsEpstein-Barr viral infectionsFood and Drug AdministrationG Protein-Coupled Receptor 29GPR29GPRCY4Gadolinium-Enhancing LesionGd-Enhancing LesionGehrig's DiseaseGene ActivationGene ExpressionGenesGrippeHCMVHHV-4HHV4HomeHomologous Chemotactic CytokinesHumanHuman Herpesvirus 4HydrocephalusHydrocephalyImmuneImmune Modulation TherapyImmune responseImmune systemImmunesImmunomodulationInfectionInfectious Mononucleosis VirusInflammatoryInfluenzaInjuryIntercrinesKO miceKidney DiseasesKnock-out MiceKnockout MiceLYT3LesionLinkLou Gehrig DiseaseLyticMHC ReceptorMR ImagingMR TomographyMRIMRIsMS patientMS treatmentMagnetic Resonance ImagingMajor Histocompatibility Complex ReceptorManuscriptsMeasurableMeasurementMeasuresMediatingMedical Imaging, Magnetic Resonance / Nuclear Magnetic ResonanceMedulla SpinalisMemoryMinorityMobile PhonesModern ManMolecular InteractionMonitorMultiple SclerosisNMR ImagingNMR TomographyNephropathyNervous System DiseasesNervous System DisorderNervous System PhysiologyNeuraxisNeuroimmuneNeurologicNeurologic DeficitNeurologic DisordersNeurologic ExaminationNeurologic functionNeurologicalNeurological DisordersNeurological functionNeurologistNeurologyNuclear Magnetic Resonance ImagingNull MouseOutcomePaired-Associate LearningPathogenicityPathologyPatientsPerformancePhysiologicPhysiologicalPlasmaPlasma SerumPopulationPosturePrognostic MarkerProteomicsProtocolProtocols documentationPublicationsPublishingReceptor ActivationRelapsing-Remitting Multiple SclerosisRenal DiseaseReportingReproducibilityResearchReticuloendothelial System, Serum, PlasmaRiskRisk-associated variantRoleSARS-CoV-2 epidemicSARS-CoV-2 global health crisisSARS-CoV-2 global pandemicSARS-CoV-2 pandemicSARS-coronavirus-2 epidemicSARS-coronavirus-2 pandemicSIS cytokinesSTRL22Salivary Gland VirusesSamplingScientific PublicationSelf AdministeredSelf AdministrationSensitivity and SpecificitySevere Acute Respiratory Syndrome CoV 2 epidemicSevere Acute Respiratory Syndrome CoV 2 pandemicSevere acute respiratory syndrome coronavirus 2 epidemicSevere acute respiratory syndrome coronavirus 2 pandemicSpecialistSpeedSpinal CordStrains Cell LinesSurfaceSystemT cell responseT-Cell Antigen ReceptorsT-Cell ProliferationT-Cell ReceptorT-Cell SubsetsT-CellsT-LymphocyteT-Lymphocyte SubsetsT-cell receptor repertoireT8 CellsT8 LymphocytesTCR repertoireTelemedicineTestingTherapeutic AgentsTimeTissuesUSFDAUnited StatesUnited States Food and Drug AdministrationValidationVariantVariationViralVirusWorkZeugmatographyactivated B cellsaged groupaged groupsaged individualaged individualsaged peopleaged personaged personsaged populationaged populationsagesaging populationanti-viral immunityantiviral immunityautoimmune conditionautoimmune disorderautoimmunity diseaseautoinflammatorybalance testingblood lipidblood-brain barrier disruptionbloodbrain barrier disruptionbrain MR imagingbrain MRIbrain damagebrain injury and spinal cord injurybrain magnetic resonance imagingbrain-injuredbrain/spinal cord injurycell killingcellular indexing of transcriptomes and epitopes by single cell sequencingcentral nervous system injurycerebral MR imagingcerebral MRIcerebral magnetic resonance imagingchemoattractant cytokinechemokinechemokine receptorclinical examclinical examinationcognitive assessmentcognitive testingcohortcoronavirus disease 2019 crisiscoronavirus disease 2019 epidemiccoronavirus disease 2019 global health crisiscoronavirus disease 2019 global pandemiccoronavirus disease 2019 health crisiscoronavirus disease 2019 pandemiccoronavirus disease 2019 public health crisiscoronavirus disease crisiscoronavirus disease epidemiccoronavirus disease pandemiccoronavirus disease-19 global pandemiccoronavirus disease-19 pandemiccultured cell linecytokinecytomegalovirus groupcytotoxicdecrease disabilitydecrease in disabilitydevelopmentaldigitaldigital markerdisabilitydisability reductionearly detectionearly therapyeffective therapyeffective treatmentepidemiologicepidemiologicalfallshomeshost responsehydrocephaliciPhoneimmune modulationimmune modulatory therapiesimmune modulatory treatmentimmune regulationimmune regulation therapyimmune regulation treatmentimmune regulatory therapyimmune system responseimmune-modulation treatmentimmunologic reactivity controlimmunomodulation therapyimmunomodulation treatmentimmunomodulator therapiesimmunomodulator treatmentimmunomodulator-based therapiesimmunomodulatoryimmunomodulatory biologicsimmunomodulatory therapiesimmunomodulatory treatmentimmunoregulationimmunoregulatoryimmunoregulatory therapyimmunoregulatory treatmentimmunoresponseimprovedimproved outcomeinfected B cellinfected B lymphocyteinjured CNSinjuriesinsular sclerosiskidney disorderlessen disabilitymigrationminimize disabilitymitigate disabilitymolecular biomarkermolecular markermulti-modalitymultimodalitymultiple sclerosis patientmultiple sclerosis therapymultiple sclerosis treatmentnatural agingnervous system functionneuroimaging biomarkerneuroimaging markerneuroimmunologic diseaseneurological diseaseneuroprotectionneuroprotectivenormal agingnormative agingnovelolder adultolder adulthoodpatients with MSpatients with multiple sclerosispeople with Multiple sclerosisphase 2 trialphase II trialpopulation agingpreventpreventingprognostic biomarkerprognostic indicatorrecruitreduction in disabilityrenal disorderresponserestraintrisk allelerisk generisk genotyperisk locirisk locusrisk variantscRNA sequencingscRNA-seqscreeningscreeningssevere acute respiratory syndrome coronavirus 2 global health crisissevere acute respiratory syndrome coronavirus 2 global pandemicsingle cell RNA-seqsingle cell RNAseqsingle cell analysissingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingslow disabilitysmart phonesmartphonesocial rolespatial memoryspinal cord and brain injurytherapeutic immunomodulationtherapeutic immunoregulationthymus derived lymphocytetissue repairtooltranscriptomicsvalidationsverbal
Get Agency plan to apply$29.99/mo · 7-day free trial · pipeline · alerts
or
— or —Get email alerts for similar roles
Description preview
Neuroimmunological diseases of the central nervous system (CNS) are a growing group of conditions, most of which are rare and not yet well understood. Effective treatments are limited. The most common of these diseases is multiple sclerosis (MS).
In its early stage, called relapsing-remitting MS (RRMS), the disease can often be managed…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click